Non-profit organization established by @ASH_Hematology to improve the lives of people affected by blood diseases and accelerate progress in #hematology.
Officer updates from ASH RC: Dr. Schiller serves as Chair; Dr. Silverstein as Secretary-Treasurer; Dr. Evens continues as Vice Chair. Dr. Crowther transitions from Chair to Director, continuing to support ASH RC’s mission. ow.ly/u9w350YQMMP#Hematology
New in Blood Advances: the ASH Research Collaborative SCD Research Network is accelerating sickle cell disease research through real-world data and community partnerships. Read now: ow.ly/4b1Q50YJ2Py#SCD#Research @Bloodjournal
Exciting leadership update from the ASH Research Collaborative (ASH RC)!
The ASH RC Board of Directors welcomes three new directors: Margaret Anderson, MA; Adama Ibrahim, EMBA; and DB Kartik, MBA, CFA. Learn more: ow.ly/pZRf50YCV9J
From idea to results: what exactly happens during a clinical study?
Our new ASH RC video, shaped by NCAB member input, describes each stage of the clinical trial lifecycle in clear, accessible language.
ow.ly/1ZHf50XwT1O#SickleCell#ClinicalResearch#ConquerSCD
From EHR-based #SickleCell phenotyping to real world voxelotor outcomes, today’s #ASH25 abstracts from the ASH Research Collaborative offer fresh insights into improving care of patients.
Explore the studies: ow.ly/w8SH50XBVIn#Hematology
This evening at #ASH25, the ASH Research Collaborative highlights tech driven research and community engagement, from AI kidney disease prediction to clinical trial literacy. Check them out from 6 PM to 8 PM! ow.ly/KAJb50XBToH#AI#Hematology#MMsm#ClinicalTrials
Don’t miss the ASH Research Collaborative’s special interest session at #ASH25, spotlighting how real-world data is being applied in multiple myeloma to support regulatory work. ow.ly/5M7M50XBVpn#MMsm#Hematology
ASH RC is improving research to build a brighter future for people with hematologic conditions. Don't miss more #ASH25 abstract presentations today!
#ConquerSCD#SickleCell#MMsm#Hematology
Join the ASH RC for a special interest session on real-world data in sickle cell disease. Learn how targeted cohort studies reveal new trends, inform care strategies, and drive innovative research approaches. ow.ly/y8OE50XExvb#ConquerSCD#SickleCell#Hematology#ASH25
#ASH25 is here and 10 accepted abstracts from the ASH RC will be presented! The research highlights kidney health in #SickleCell disease, treatment outcomes and high-risk disease in multiple myeloma, and more. ow.ly/S0US50XBuUO#ConquerSCD#MMsm
How does #SickleCell disease (SCD) research help to reduce bias in care and treatment?
This new ASH RC video, developed in partnership with NCAB members, highlights how inclusive, community-driven research can build trust and improve outcomes.
🎥 ow.ly/YHgv50XAVcN
New videos just dropped on the ASH RC Clinical Trials E-Library!
Our NCAB working group helped bring these resources to life, from scripting to character development, to make SCD research easier to understand and more accessible to all.
Watch now: ashresearchcollaborative.org…
Joining a clinical trial is your decision. You can choose to participate or not, and you can change your mind at any time — your rights and privacy are always protected.
Learn more from the clinical trials resource: ow.ly/rqSe50X3Lts#Research#Hematology#HemeOnc
Curious about how your data is protected in clinical trials? Learn what safeguards are in place, from de-identifying information to ethical oversight, so you can participate in research with confidence.
Visit the clinical trials resource library today: ow.ly/a6sH50X3KrP
Now available: the 2025 Sickle Cell Disease Data Hub Report — the first report from the ASH RC’s SCD Data Hub Program. These data, based on real world data, lay the foundation for future research, policy, and improved care for the SCD community.
🔗 ow.ly/TYIO50WbX8B